Nov 8, 2024, 19:07
SPCC – Overview and clarification of the current HR+ HER2- EBC treatment landscape
SPCC shared on LinkedIn:
“Save the date for our next live session: ‘Overview and clarification of the current HR+ HER2- EBC treatment landscape’.
Topics:
∙ Clarification of current treatment guidelines – perspectives of clinical implementation?
∙ Benefit/cost ratio of treatment escalation and diagnostic steps vs recurrence risk
27 November – 18:00 CET
Register here.
This webinar is supported by an unrestricted educational grant from Eli Lilly.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 23, 2024, 14:48
Nov 23, 2024, 14:32
Nov 23, 2024, 14:04
Nov 23, 2024, 13:58
Nov 23, 2024, 13:32